These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
283 related articles for article (PubMed ID: 32617743)
41. Molecular genetic features of meningiomas. Makashova ES; Lasunin NV; Galkin MV; Zolotova SV; Karandasheva KO; Golanov AV Zh Vopr Neirokhir Im N N Burdenko; 2023; 87(4):101-106. PubMed ID: 37650282 [TBL] [Abstract][Full Text] [Related]
42. Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations. Brastianos PK; Horowitz PM; Santagata S; Jones RT; McKenna A; Getz G; Ligon KL; Palescandolo E; Van Hummelen P; Ducar MD; Raza A; Sunkavalli A; Macconaill LE; Stemmer-Rachamimov AO; Louis DN; Hahn WC; Dunn IF; Beroukhim R Nat Genet; 2013 Mar; 45(3):285-9. PubMed ID: 23334667 [TBL] [Abstract][Full Text] [Related]
43. Molecular genetics of meningiomas: Building the roadmap towards personalized therapy. Peyre M; Kalamarides M Neurochirurgie; 2018 Mar; 64(1):22-28. PubMed ID: 25245924 [TBL] [Abstract][Full Text] [Related]
44. Advances in Molecular Biological and Translational Studies in World Health Organization Grades 2 and 3 Meningiomas: A Literature Review. Okano A; Miyawaki S; Teranishi Y; Ohara K; Hongo H; Sakai Y; Ishigami D; Nakatomi H; Saito N Neurol Med Chir (Tokyo); 2022 Aug; 62(8):347-360. PubMed ID: 35871574 [TBL] [Abstract][Full Text] [Related]
45. Related mechanisms, current treatments, and new perspectives in meningioma. Inetas-Yengin G; Bayrak OF Genes Chromosomes Cancer; 2024 May; 63(5):e23248. PubMed ID: 38801095 [TBL] [Abstract][Full Text] [Related]
46. Germline and somatic mutations in meningiomas. Smith MJ Cancer Genet; 2015 Apr; 208(4):107-14. PubMed ID: 25857641 [TBL] [Abstract][Full Text] [Related]
47. Meningioma: current updates on genetics, classification, and mouse modeling. Szulzewsky F; Thirimanne HN; Holland EC Ups J Med Sci; 2024; 129():. PubMed ID: 38571886 [TBL] [Abstract][Full Text] [Related]
48. Meningiomas induced by low-dose radiation carry structural variants of NF2 and a distinct mutational signature. Sahm F; Toprak UH; Hübschmann D; Kleinheinz K; Buchhalter I; Sill M; Stichel D; Schick M; Bewerunge-Hudler M; Schrimpf D; Zadeh G; Aldape K; Herold-Mende C; Beck K; Staszewski O; Prinz M; Harosh CB; Eils R; Sturm D; Jones DTW; Pfister SM; Paulus W; Ram Z; Schlesner M; Grossman R; von Deimling A Acta Neuropathol; 2017 Jul; 134(1):155-158. PubMed ID: 28474103 [No Abstract] [Full Text] [Related]
49. A Practical Overview on the Molecular Biology of Meningioma. Delgado-López PD; Cubo-Delgado E; González-Bernal JJ; Martín-Alonso J Curr Neurol Neurosci Rep; 2020 Nov; 20(12):62. PubMed ID: 33136206 [TBL] [Abstract][Full Text] [Related]
50. De novo and secondary anaplastic meningiomas: a study of clinical and histomolecular prognostic factors. Peyre M; Gauchotte G; Giry M; Froehlich S; Pallud J; Graillon T; Bielle F; Cazals-Hatem D; Varlet P; Figarella-Branger D; Loiseau H; Kalamarides M Neuro Oncol; 2018 Jul; 20(8):1113-1121. PubMed ID: 29216385 [TBL] [Abstract][Full Text] [Related]
51. Genetic and epigenetic alteration of the NF2 gene in sporadic meningiomas. Lomas J; Bello MJ; Arjona D; Alonso ME; Martinez-Glez V; Lopez-Marin I; Amiñoso C; de Campos JM; Isla A; Vaquero J; Rey JA Genes Chromosomes Cancer; 2005 Mar; 42(3):314-9. PubMed ID: 15609345 [TBL] [Abstract][Full Text] [Related]
52. Non-NF2 mutations have a key effect on inhibitory immune checkpoints and tumor pathogenesis in skull base meningiomas. Hao S; Huang G; Feng J; Li D; Wang K; Wang L; Wu Z; Wan H; Zhang L; Zhang J J Neurooncol; 2019 Aug; 144(1):11-20. PubMed ID: 31177425 [TBL] [Abstract][Full Text] [Related]
54. A new amplicon-based gene panel for next generation sequencing characterization of meningiomas. Mawrin C; Koch R; Waldt N; Sandalcioglu IE; Braunsdorf WEK; Warnke JP; Goehre F; Meisel HJ; Ewald C; Neyazi S; Schüller U; Kirches E Brain Pathol; 2022 Mar; 32(2):e13046. PubMed ID: 35213080 [TBL] [Abstract][Full Text] [Related]
55. Towards Molecular Classification of Meningioma: Evolving Treatment and Diagnostic Paradigms. Proctor DT; Ramachandran S; Lama S; Sutherland GR World Neurosurg; 2018 Nov; 119():366-373. PubMed ID: 30138732 [TBL] [Abstract][Full Text] [Related]
56. Quantitative analysis of neurofibromatosis type 2 gene transcripts in meningiomas supports the concept of distinct molecular variants. Wellenreuther R; Waha A; Vogel Y; Lenartz D; Schramm J; Wiestler OD; von Deimling A Lab Invest; 1997 Dec; 77(6):601-6. PubMed ID: 9426397 [TBL] [Abstract][Full Text] [Related]
57. Whole exome sequencing in a case of sporadic multiple meningioma reveals shared NF2, FAM109B, and TPRXL mutations, together with unique SMARCB1 alterations in a subset of tumor nodules. Torres-Martín M; Kusak ME; Isla A; Burbano RR; Pinto GR; Melendez B; Castresana JS; Rey JA Cancer Genet; 2015 Jun; 208(6):327-32. PubMed ID: 25981829 [TBL] [Abstract][Full Text] [Related]
58. Das A; Martinez Santos JL; Alshareef M; Porto GBF; Infinger LK; Vandergrift WA; Lindhorst SM; Varma AK; Patel SJ; Cachia D Cancer Invest; 2020 Jul; 38(6):349-355. PubMed ID: 32441531 [No Abstract] [Full Text] [Related]
59. Meningiomas: A review of general, histopathological, clinical and molecular characteristics. Salles D; Santino SF; Malinverni ACM; Stávale JN Pathol Res Pract; 2021 Jul; 223():153476. PubMed ID: 33991850 [TBL] [Abstract][Full Text] [Related]
60. [The molecular genetics of meningiomas and genotypic/phenotypic correlations]. Dezamis E; Sanson M Rev Neurol (Paris); 2003 Sep; 159(8-9):727-38. PubMed ID: 13679715 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]